Allogene Therapeutics, Inc.ALLONASDAQ
Loading
Cash Flow Under PressureContracting
Percentile Rank50
Studio
Year-over-Year Change

Cash generated from core business operations

Latest
$-149.25M
Near historical average
Percentile
P50
Within normal range
Streak
2 yr
Consecutive growthContracting
Average
$-143.30M
Historical baseline
PeriodValueYoY Change
TTM$-149.25M+25.5%
2024$-200.30M+15.7%
2023$-237.73M-7.8%
2022$-220.52M-19.3%
2021$-184.81M-60.6%
2020$-115.09M+16.2%
2019$-137.35M-207.6%
2018$-44.65M-
2017$0.00-